The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Allergan plc

NYSE: AGN
Last

(U.S.) $249.07

Today's change+2.66 +1.08%
Updated July 20 4:03 PM EDT. Delayed by at least 15 minutes.
 

Allergan plc

NYSE: AGN
Last

(U.S.) $249.07

Today's change+2.66 +1.08%
Updated July 20 4:03 PM EDT. Delayed by at least 15 minutes.

Allergan plc Hits New 100-day High

Allergan plc closed up Thursday by (U.S.)$2.66 or 1.08% to (U.S.)$249.07 and setting a new 100-day high. Over the last five days, shares have gained 2.02% and are currently 4.67% off of the 52-week high. Shares have underperformed the S&P 500 by 12.97% during the last year.

Key company metrics

  • Open(U.S.) $247.42
  • Previous close(U.S.) $246.41
  • High(U.S.) $251.63
  • Low(U.S.) $247.09
  • Bid / Ask(U.S.) $247.74 / (U.S.) $255.78
  • YTD % change+18.60%
  • Volume2,398,072
  • Average volume (10-day)1,386,779
  • Average volume (1-month)1,849,445
  • Average volume (3-month)2,238,319
  • 52-week range(U.S.) $184.50 to (U.S.) $261.27
  • Beta1.16
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward15.32×
  • Forward PEG1.16×
  • Indicated annual dividend(U.S.) $2.80
  • Dividend yield1.12%
  • Trailing EPS(U.S.) -$10.56
Updated July 20 4:03 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.13%Sector:HealthcareIndustry:Pharmaceuticals - Diversified

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue3,5733,8643,6223,685
Total other revenue--------
Total revenue3,5733,8643,6223,685
Gross profit3,1233,3853,1603,243
Total cost of revenue450480462442
Total operating expense4,4794,7643,8894,172
Selling / general / administrative1,1851,2771,1571,210
Research & development1,1001,340665905
Depreciation / amortization1,7361,6391,6091,633
Interest expense (income), net operating--------
Unusual expense (income)729-5-18
Other operating expenses, total--------
Operating income-906-900-266-488
Interest income (expense), net non-operating-290-293-324-346
Gain (loss) on sale of assets--------
Other--------
Income before tax-3,093-1,111-539-681
Income after tax-2,561-40-380-423
Income tax, total-532-1,071-159-258
Net income-2,565-115,220-502
Total adjustments to net income-70-70-70-70
Net income before extra. items-2,562-42-382-424
Minority interest-1-2-2-2
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-2,632-112-452-494
Inc. avail. to common incl. extra. items-2,635-7015,150-571
Diluted net income-2,635-7015,150-571
Dilution adjustment--------
Diluted weighted average shares335356393396
Diluted EPS excluding extraordinary itemsvalue per share-7.85-0.31-1.15-1.25
Dividends per sharevalue per share0.70--0.000.00
Diluted normalized EPSvalue per share-7.84-0.26-1.16-1.28